Why Is Iovance (IOVA) Stock Price Up 12.52% Today, August 20? Strong Cancer Therapy Sales and Analyst Upgrades Extend the Rally
Iovance Biotherapeutics (IOVA) rose 12.52% to $8.99 on August 20, 2026 as investors extended the post-earnings reappraisal of Amtagvi sales and guidance potential. Read the daily analysis of Iovance's commercial execution outlook, momentum risk and key technical levels.